Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats

Fenofibrate is a selective peroxisome proliferator-activated receptor α (PPARα) activator and is prescribed to treat hyperlipidemia. The mechanism through which PPARα agonists reduce food intake, body weight, and adiposity remains unclear. One explanation for the reduction of food intake is that fen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Park, Mi-Kyoung, Han, Ying, Kim, Mi Sun, Seo, Eunhui, Kang, Soojeong, Park, So-Young, Koh, Hyeongjong, Kim, Duk Kyu, Lee, Hye-Jeong
Format: Artigo
Idioma:Inglês
Publicat: The Korean Physiological Society and The Korean Society of Pharmacology 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3394920/
https://ncbi.nlm.nih.gov/pubmed/22802699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2012.16.3.181
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars